Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand
Stopped early · Phase 2
Conditions studied: Ovarian Cancer
In brief
Prognosis for many carcinomas, including ovarian carcinoma, is dependent on a complete surgical resection, also known as a R0 resection. At present, the ability to perform a complete resection with negative margins is limited by the surgeon's ability to palpate and visualize the tumor and its margins. Therefore, in order to reduce operative morbidity and costs while maintaining or improving surgical and oncologic outcomes, the investigators must develop technologies that improve visualization of the primary tumor and occult metastases, real time, during surgery. Recent research has demonstrated that the use of fluorescent probes that recognize cancer specific antigens can be used for this purpose when visualized using a prototype near-infrared multispectral imaging system. This investigation will determine if folate-FITC, a fluorescent probe that recognizes the folate receptor (present in \> 90% of ovarian cancers) can facilitate surgical resection and detect tumor nodules not visible to the naked eye.
Key facts
- Study ID
- NCT01511055
- Run by
- Mayo Clinic
- People needed
- 27
- Starts
- 2012-01-01
- Expected to finish
- 2014-06-01
- Last updated by the study team
- 2020-11-12
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women who are:
- Diagnosed with or at high clinical suspicion of primary ovarian cancer by either radiologic imaging or physical examination or biopsy or serum tumor markers
- Scheduled to undergo surgical cytoreduction via laparotomy
- At least 18 years of age
- Capable and willing to provide informed consent
You may not qualify if…
- Women with:
- Known sarcomatous histologies
- Recurrent ovarian cancer
- Planned surgical approach via laparoscopy or robotic surgery
- A history of anaphylactic reactions to Folate-FITC or insects
- Inability or unwillingness to provide informed consent
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.